MAPT and neurodegenerative disease: Therefore, developing sufficient r-mTBI models and considering more factors such as species, gender, age, acute phase, subacute phase, and chronic phase, provides more sufficient evidence on how r-mTBI leads to pathological tau formation, metal homeostasis disorders, and motor and cognitive deficits, thereby jointly leading to neurodegenerative diseases.